No takes yet. Share an insight, caveat, or question.
Policy review reveals variable regulatory requirements for clinical trial diversity in older populations, highlighting the need for enforceable inclusion standards.
Markham et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: